Nephrodite Achieves First Multi-Day Large-Animal Success for Implantable Kidney Device

Nephrodite Achieves Major Breakthrough as Holly Device Delivers Continuous Kidney Function in Multi-Day Large Animal Study Nephrodite a medical device innovator advancing an implantable, fully mechanical renal replacement system, has announced highly encouraging results from a landmark multi-day large animal…

Read MoreNephrodite Achieves First Multi-Day Large-Animal Success for Implantable Kidney Device
Summit

Summit Therapeutics Announces Inducement Equity Grants Under Nasdaq Rule 5635(c)(4)

Summit Therapeutics Issues Inducement Awards Pursuant to Nasdaq Listing a biopharmaceutical company focused on developing innovative therapies for serious diseases, today announced the issuance of inducement equity awards in the form of stock options to nine newly hired employees. The…

Read MoreSummit Therapeutics Announces Inducement Equity Grants Under Nasdaq Rule 5635(c)(4)
Atropos

Atropos Health Advances Oncology Precision Medicine with New AI Algorithms

Atropos Health Strengthens Precision Oncology Platform with Advanced AI for Rare Disease Monitoring and Integration of ASCO Clinical Guidelines Atropos Health, a leader in transforming real-world clinical data into personalized real-world evidence (RWE), has announced a major expansion of its…

Read MoreAtropos Health Advances Oncology Precision Medicine with New AI Algorithms
Serent

Serent Capital Exits Axiom Medical After Strategic Investment by NMS Capital

Seven-year partnership concludes as Axiom Medical secures new growth capital to accelerate national expansion a growth-focused private equity firm known for partnering with founder-led and entrepreneur-driven businesses, today announced the successful recapitalization of Axiom Medical, a leading provider of technology-enabled…

Read MoreSerent Capital Exits Axiom Medical After Strategic Investment by NMS Capital